What is the current Europe Cancer Biomarkers Market size?

The Europe Cancer Biomarkers Market is projected to register a CAGR of 11.60% during the forecast period (2024-2029) Read More

Who are the key players in Europe Cancer Biomarkers Market?

Abbott Laboratories Inc, F. Hoffmann-La Roche Ltd, Illumina Inc, Thermo Fisher Scientific and Biomerieux are the major companies operating in the Europe Cancer Biomarkers Market. Read More

What years does this Europe Cancer Biomarkers Market cover?

The report covers the Europe Cancer Biomarkers Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Cancer Biomarkers Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Europe Cancer Biomarkers Market Share

Statistics for the 2023 & 2024 Europe Cancer Biomarkers market share, created by Mordor Intelligence™ Industry Reports. Europe Cancer Biomarkers share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Europe Cancer Biomarkers Industry

The European cancer biomarkers market is highly competitive and consists of a few major players. Some companies currently dominating the market include Abbott Laboratories Inc., Agilent Technologies, Ambry Genetics, Biomerieux, Celera Corporation (Quest Diagnostics), F. Hoffmann-La Roche Ltd, Hologic Inc., Illumina Inc., and Thermo Fisher Scientific. Furthermore, some of the major market players, such as Novartis and Gilead in cancer therapy, are from Europe, one of the factors boosting the R&D activities in the region.